Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 6 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 2 institutions in 1 country.
Ekaterina StepanenkoLaboratory of Molecular Neurogenetics and Innate Immunity, National Research Centre "Kurchatov Institute", Moscow 123182, Russia.
Natalia BondarevaLaboratory for Chlamydiosis, National Research Center for Epidemiology and Microbiology Named after N. F. Gamaleya, Russian Health Ministry, Moscow 123098, Russia.
Anna SheremetLaboratory for Chlamydiosis, National Research Center for Epidemiology and Microbiology Named after N. F. Gamaleya, Russian Health Ministry, Moscow 123098, Russia.
Elena FedinaLaboratory for Chlamydiosis, National Research Center for Epidemiology and Microbiology Named after N. F. Gamaleya, Russian Health Ministry, Moscow 123098, Russia.
Alexei TikhomirovLaboratory of Molecular Neurogenetics and Innate Immunity, National Research Centre "Kurchatov Institute", Moscow 123182, Russia.
Tatiana GerasimovaLaboratory of Molecular Neurogenetics and Innate Immunity, National Research Centre "Kurchatov Institute", Moscow 123182, Russia.ORCID 0000-0002-3858-4561
Daniil PoberezhniyLaboratory of Molecular Neurogenetics and Innate Immunity, National Research Centre "Kurchatov Institute", Moscow 123182, Russia.ORCID 0000-0001-7281-4714
Irina MakarovaLaboratory of Molecular Neurogenetics and Innate Immunity, National Research Centre "Kurchatov Institute", Moscow 123182, Russia.
Vyacheslav TarantulLaboratory of Molecular Neurogenetics and Innate Immunity, National Research Centre "Kurchatov Institute", Moscow 123182, Russia.
Nailya ZigangirovaLaboratory for Chlamydiosis, National Research Center for Epidemiology and Microbiology Named after N. F. Gamaleya, Russian Health Ministry, Moscow 123098, Russia.
Valentina NenashevaLaboratory of Molecular Neurogenetics and Innate Immunity, National Research Centre "Kurchatov Institute", Moscow 123182, Russia.ORCID 0000-0003-3985-6466
Kurchatov Institute · RUD. Mendeleyev University of Chemical Technology of Russia · RU
Funding
Russian Science Foundation 23-25-00157
6 · The paper itself
Abstract
Bacterial infections represent an unsolved problem today since bacteria can evade antibiotics and suppress the host's immune response. A family of TRIM proteins is known to play a role in antiviral defense. However, the data on the involvement of the corresponding genes in the antibacterial response are limited. Here, we used RT-qPCR to profile the transcript levels of
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.